BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lescano MA, Tavares LC, Santos PCJL. Juvenile hemochromatosis: HAMP mutation and severe iron overload treated with phlebotomies and deferasirox. World J Clin Cases 2017; 5(10): 381-383 [PMID: 29085829 DOI: 10.12998/wjcc.v5.i10.381]
URL: https://www.wjgnet.com/2307-8960/full/v5/i10/381.htm
Number Citing Articles
Robert A. Norman, Trupal Patel, Tam H. Nguyen. Geriatric Gastroenterology2020; : 1 doi: 10.1007/978-3-319-90761-1_90-1
Aline Morgan Alvarenga, Pierre Brissot, Paulo Caleb Junior Lima Santos. Haemochromatosis revisitedWorld Journal of Hepatology 2022; 14(11): 1931-1939 doi: 10.4254/wjh.v14.i11.1931
Jing Hu, Yuan Li, Li Zhang, Guangxin Peng, Fengkui Zhang, Xin Zhao. Iron overload due to SLC40A1 mutation of type 4 hereditary hemochromatosisMedical Molecular Morphology 2023; 56(3): 233 doi: 10.1007/s00795-023-00359-8
Junhua Miao, Mutao Xu, Yuhuan Kuang, Shuhong Pan, Jianyuan Hou, Pengxiu Cao, Xianglin Duan, Yanzhong Chang, Habelhah Hasem, Nan Zhou, Ke Tan, Yumei Fan. Deferasirox protects against hydrogen peroxide-induced cell apoptosis by inhibiting ubiquitination and degradation of p21WAF1/CIP1Biochemical and Biophysical Research Communications 2020; 524(3): 736 doi: 10.1016/j.bbrc.2020.01.155
Robert A. Norman, Trupal Patel, Tam H. Nguyen. Geriatric Gastroenterology2021; : 2219 doi: 10.1007/978-3-030-30192-7_90
Darrell H. G. Crawford, Grant A. Ramm, Kim R. Bridle, Amanda J. Nicoll, Martin B. Delatycki, John K. Olynyk. Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the LiverHepatology International 2023; 17(3): 522 doi: 10.1007/s12072-023-10510-3
Wanhui Kang, Alexa Barad, Andrew G Clark, Yiqin Wang, Xu Lin, Zhenglong Gu, Kimberly O O'Brien. Ethnic Differences in Iron StatusAdvances in Nutrition 2021; 12(5): 1838 doi: 10.1093/advances/nmab035
Rodolfo D. Cancado, Aline Morgan Alvarenga, Paulo Caleb JL Santos. HFE hemochromatosis: an overview about therapeutic recommendationsHematology, Transfusion and Cell Therapy 2022; 44(1): 95 doi: 10.1016/j.htct.2021.06.020